{"gao_id": "GAO-22-104453", "published": "2022-01-19T12:00:00Z", "released": "2022-01-19T07:00:00Z", "summary": "Since May 2020, federal efforts to speed the development, manufacturing, and distribution of COVID-19 vaccines\u2014previously known as Operation Warp Speed\u2014have been led by the Departments of Health and Human Services and Defense. HHS took over sole responsibility for the work at the beginning of 2022. It's unclear whether HHS is ready to fully assume all responsibilities, especially those formerly led by DOD. HHS has assessed...", "title": "COVID-19: HHS and DOD Transitioned Vaccine Responsibilities to HHS, but Need to Address Outstanding Issues", "topics": ["Manufacturing", "pandemics", "Supply chain management", "Project management", "Best practices", "Clinical trials", "Health care", "Public health emergencies", "Health Care", "Vaccinations"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-22-104453", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-22-104453-highlights.pdf"}, {"title": "Full Report (59 pages)", "url": "https://www.gao.gov/assets/gao-22-104453.pdf"}, {"title": "Accessible PDF (70 pages)", "url": "https://www.gao.gov/assets/720/718566.pdf"}]}